BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2166635)

  • 1. From channels to cats: an overview of isradipine pharmacology.
    Rüegg UT; Hof RP
    Cor Vasa; 1990; 32(2 Suppl 1):12-22. PubMed ID: 2166635
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular effects of isradipine (Lomir) with special emphasis on haemodynamics and antihypertensive efficacy. A review.
    Dahlöf B
    Cor Vasa; 1990; 32(2 Suppl 1):23-34. PubMed ID: 2143458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of the calcium antagonist isradipine.
    Rüegg UT; Hof RP
    Drugs; 1990; 40 Suppl 2():3-9. PubMed ID: 2150637
    [No Abstract]   [Full Text] [Related]  

  • 4. [Isradipine, a calcium antagonist in hypertension].
    Christensen HR; Graudal N
    Ugeskr Laeger; 1990 Aug; 152(34):2448-50. PubMed ID: 2144928
    [No Abstract]   [Full Text] [Related]  

  • 5. Isradipine in hypertension. Proceedings of an international symposium. Athens, Greece, October 21, 1988.
    Am J Med; 1989 Apr; 86(4A):1-146. PubMed ID: 2523643
    [No Abstract]   [Full Text] [Related]  

  • 6. Isradipine (Lomir) in the treatment of hypertension. Introduction.
    Widimský J
    Cor Vasa; 1990; 32(2 Suppl 1):1. PubMed ID: 2143456
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of calcium antagonists in the treatment of arterial hypertension].
    Velasco M; Negrín C
    Invest Clin; 1997 Nov; 38 Suppl 2():65-72. PubMed ID: 9471233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isradipine (Lomir) in the treatment of hypertension. An international satellite symposium of the Vth International Congress on Pulmonary Circulation. Prague, July 6, 1989. Proceedings.
    Cor Vasa; 1990; 32(2 Suppl 1):1-80. PubMed ID: 2143457
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of the international literature on isradipine in hypertension (Lomir/Dynacirc).
    Soland FX
    Cor Vasa; 1990; 32(2 Suppl 1):61-72. PubMed ID: 2143461
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium antagonists in experimental atherosclerosis. Use-dependence of isradipine: a potential explanation for enhanced action in atherosclerotic animals and tissue selectivity.
    Hof RP; Rüegg UT
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):107S-113S. PubMed ID: 1826999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of isradipine in essential hypertension.
    Grossman E; Messerli FH; Oren S; Nunez B; Garavaglia GE
    Am J Cardiol; 1991 Jul; 68(1):65-70. PubMed ID: 1829320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium antagonists in the treatment of arterial hypertension].
    Raczka A
    Pol Tyg Lek; 1983 Jan; 38(3):95-7. PubMed ID: 6866828
    [No Abstract]   [Full Text] [Related]  

  • 14. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-channel blockers and systemic hypertension.
    Frishman WH; Charlap S; Ocken S; Spivack C
    J Clin Hypertens; 1985 Jun; 1(2):107-22. PubMed ID: 3915318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isradipine in arterial hypertension in motor vehicle drivers].
    Aramisova RM; El'garov AA
    Med Tr Prom Ekol; 1996; (8):21-3. PubMed ID: 8963604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic response, safety, and efficacy of isradipine in the treatment of essential hypertension.
    Dahlöf B
    Am J Med; 1989 Apr; 86(4A):19-26. PubMed ID: 2523651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antihypertensive therapy and vascular wall protection with special reference to calcium antagonists].
    Faulhaber HD
    Z Arztl Fortbild (Jena); 1993; 87(9 Suppl 5):1-5. PubMed ID: 8237075
    [No Abstract]   [Full Text] [Related]  

  • 19. Transduction pathways for noradrenaline-induced modulation of calcium channels in vascular smooth muscle.
    Mironneau J
    Jpn J Pharmacol; 1992; 58 Suppl 2():87P-95P. PubMed ID: 1324371
    [No Abstract]   [Full Text] [Related]  

  • 20. Beyond lowering of blood pressure. . .isradipine. Satellite symposium of the thirteenth scientific meeting of the International Society of Hypertension.
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):83S-209S. PubMed ID: 1827025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.